163 related articles for article (PubMed ID: 8000512)
1. Small duct cholangitis induced by N-formyl L-methionine L-leucine L-tyrosine in rats.
Yamada S; Ishii M; Liang LS; Yamamoto T; Toyota T
J Gastroenterol; 1994 Oct; 29(5):631-6. PubMed ID: 8000512
[TBL] [Abstract][Full Text] [Related]
2. Macrophages are essential for lymphocyte infiltration in formyl peptide-induced cholangitis in rat liver.
Yamada S; Ishii M; Kisara N; Nagatomi R; Toyota T
Liver; 1999 Jun; 19(3):253-8. PubMed ID: 10395046
[TBL] [Abstract][Full Text] [Related]
3. Intrahepatic bile duct loss in primary sclerosing cholangitis: a quantitative study.
Casali AM; Carbone G; Cavalli G
Histopathology; 1998 May; 32(5):449-53. PubMed ID: 9639121
[TBL] [Abstract][Full Text] [Related]
4. Autoimmune diseases of the liver and biliary tract and overlap syndromes in childhood.
Maggiore G; Riva S; Sciveres M
Minerva Gastroenterol Dietol; 2009 Mar; 55(1):53-70. PubMed ID: 19212308
[TBL] [Abstract][Full Text] [Related]
5. A longitudinal study of histologic and immunohistologic changes in an experimental model of sclerosing cholangitis.
Bedossa P; Houry S; Bacci J; Martin E; Lemaigre G; Huguier M
Virchows Arch A Pathol Anat Histopathol; 1989; 414(2):165-71. PubMed ID: 2492694
[TBL] [Abstract][Full Text] [Related]
6. The spectrum of bile duct lesions in end-stage primary sclerosing cholangitis.
Harrison RF; Hubscher SG
Histopathology; 1991 Oct; 19(4):321-7. PubMed ID: 1937411
[TBL] [Abstract][Full Text] [Related]
7. Precancerous bile duct pathology in end-stage primary sclerosing cholangitis, with and without cholangiocarcinoma.
Lewis JT; Talwalkar JA; Rosen CB; Smyrk TC; Abraham SC
Am J Surg Pathol; 2010 Jan; 34(1):27-34. PubMed ID: 19898228
[TBL] [Abstract][Full Text] [Related]
8. Aberrant expression of stem cell factor on biliary epithelial cells and peribiliary infiltration of c-kit-expressing mast cells in hepatolithiasis and primary sclerosing cholangitis: a possible contribution to bile duct fibrosis.
Tsuneyama K; Kono N; Yamashiro M; Kouda W; Sabit A; Sasaki M; Nakanuma Y
J Pathol; 1999 Dec; 189(4):609-14. PubMed ID: 10629565
[TBL] [Abstract][Full Text] [Related]
9. Cystic dilatation of intrahepatic bile ducts in primary sclerosing cholangitis.
Genève J; Dubuc N; Mathieu D; Zafrani ES; Dhumeaux D; Métreau JM
J Hepatol; 1990 Sep; 11(2):196-9. PubMed ID: 2254629
[TBL] [Abstract][Full Text] [Related]
10. Intrahepatic segmental primary sclerosing cholangitis: report of a case.
Matsumoto T; Ajiki T; Matsumoto I; Tominaga M; Hori H; Mita Y; Fujita T; Fujino Y; Suzuki Y; Ku Y; Kuroda Y
Surg Today; 2006; 36(7):638-41. PubMed ID: 16794801
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and risk factors for gallbladder neoplasia in patients with primary sclerosing cholangitis: evidence for a metaplasia-dysplasia-carcinoma sequence.
Lewis JT; Talwalkar JA; Rosen CB; Smyrk TC; Abraham SC
Am J Surg Pathol; 2007 Jun; 31(6):907-13. PubMed ID: 17527079
[TBL] [Abstract][Full Text] [Related]
12. [A clinical and pathological analysis of 22 cases of primary sclerosing cholangitis].
Liu HH; Fu JL; Luo SQ; Sun YL; Dong JH; Guo TS; Wang FS
Zhonghua Gan Zang Bing Za Zhi; 2013 Feb; 21(2):125-8. PubMed ID: 23663885
[TBL] [Abstract][Full Text] [Related]
13. A novel rat model of chronic fibrosing cholangitis induced by local administration of a hapten reagent into the dilated bile duct is associated with increased TNF-alpha production and autoantibodies.
Orth T; Neurath M; Schirmacher P; Galle PR; Mayet WJ
J Hepatol; 2000 Dec; 33(6):862-72. PubMed ID: 11131446
[TBL] [Abstract][Full Text] [Related]
14. Diffuse biliary tract involvement mimicking primary sclerosing cholangitis in an experimental model of chronic graft-versus-host disease in mice.
Nonomura A; Kono N; Minato H; Nakanuma Y
Pathol Int; 1998 Jun; 48(6):421-7. PubMed ID: 9702853
[TBL] [Abstract][Full Text] [Related]
15. Intrahepatic cholangiectases and large-duct obliteration in primary sclerosing cholangitis.
Ludwig J; MacCarty RL; LaRusso NF; Krom RA; Wiesner RH
Hepatology; 1986; 6(4):560-8. PubMed ID: 3525365
[TBL] [Abstract][Full Text] [Related]
16. Involvement of peribiliary glands in primary sclerosing cholangitis: a histopathologic study.
Terasaki S; Nakanuma Y; Unoura M; Kaneko S; Kobayashi K
Intern Med; 1997 Nov; 36(11):766-70. PubMed ID: 9392346
[TBL] [Abstract][Full Text] [Related]
17. Enterohepatic circulation of bacterial chemotactic peptide in rats with experimental colitis.
Hobson CH; Butt TJ; Ferry DM; Hunter J; Chadwick VS; Broom MF
Gastroenterology; 1988 Apr; 94(4):1006-13. PubMed ID: 3345870
[TBL] [Abstract][Full Text] [Related]
18. Biliary dysplasia, cell proliferation and nuclear DNA-fragmentation in primary sclerosing cholangitis with and without cholangiocarcinoma.
Bergquist A; Glaumann H; Stål P; Wang GS; Broomé U
J Intern Med; 2001 Jan; 249(1):69-75. PubMed ID: 11168786
[TBL] [Abstract][Full Text] [Related]
19. Bile canalicular abnormalities in the early phase of a mouse model of sclerosing cholangitis.
Miyao M; Ozeki M; Abiru H; Manabe S; Kotani H; Tsuruyama T; Tamaki K
Dig Liver Dis; 2013 Mar; 45(3):216-25. PubMed ID: 23107486
[TBL] [Abstract][Full Text] [Related]
20. Peribiliary vascular plexus in primary sclerosing cholangitis and primary biliary cirrhosis.
Washington K; Clavien PA; Killenberg P
Hum Pathol; 1997 Jul; 28(7):791-5. PubMed ID: 9224746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
